Piramal Pharma

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue1,9922,1092,1832,7982,359
Expenses2,1102,1702,2462,5932,386
EBITDA165.10224.29238.97506.57284.61
Operating Profit7.1336.24-4.62125.9980.62
Profit Before Tax-79.02-46.18-93.8643.00-7.46
Net Profit-81.70-99.22-136.19-8.83-69.39
Financial Ratios
Operating Profit Margin10.57%11.70%9.73%12.51%13.40%
Net Profit Margin-4.83%-4.85%-5.40%4.18%-3.06%
Earning Per Share (Diluted)-0.62-0.75-1.03-0.07-0.52
Dividends Per Share0.000.000.000.000.00